1Palemans, W, Vantrappen, G. Oesophageal disease in the elderly. Clin Gastroenterol 1985; 14: 635–56.
2Andrews, GR, Haneman, B, Arnold, BJ, Booth, JC, Taylor, K. Atrophic gastritis in the aged. Aust Ann Med 1967; 61: 230–35.
3Holt, PR, Rosenberg, IH, Russell, RM. Causes and consequences of hypochlorhydria in the elderly. Dig Dis Sci 1989; 34: 933–37.
4Strickland, RG, Bhathal, PS, Korman, MG, Hansky, J. Serum gastrin and antal mucosa in atrophic gastritis. BMJ 1971; 4: 451–53.
5Dooley, CP, Cohen, H, Fitzgibbons, PL et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562–66.
6Sobala, GM, King, RF, Axon, AT, Dixon, MF. Reflux gastritis in the intact stomach. J Clin Pathol 1990; 43: 303–306.
7Holt, PR. The small intestine. Clin Gastroenterol 1985; 14: 689–723.
8Dent, J. Recent reviews on the pathogenesis of gastro-oesophageal reflux disease. Baillières Clin Gastroenterol 1987; 1: 727–46.
9Moran, BJ, Taylor, MB, Johnson, CD. Percutaneous endoscopic gastrostomy. Br J Surg 1990; 77: 858–62.
10Worman, LW. Pharyngeo-oesophageal diverticulum –excision or incision. Surgery 1980; 87: 236–37.
11Weinbeck, M, Berges, W, Freiling, T. Therapeutic advances in oesophageal motility disorders. Baillières Clin Gastroenterol 1987; 1: 857–67.
12Blackwell, JN, Castell, DO. Oesophageal motility: recent advances and implications. Clin Sci 1984; 104: 477–83.
13Clouse, RE, Staiano, A. Contraction abnormalities of the oesophageal body in patients referred for manometry: a new approach to manometric classification. Dig Dis Sci 1983; 28: 784–91.
14Dimarino, AJ, Cohen, S. Characteristics of lower oesophageal sphincter function in symptomatic diffuse oesophageal spasm. Gastroenterology 1974; 66: 1–6.
15Csendes, A, Braghetto, I, Henriquez, A, Cortes, A. Late results of a prospective randomised study comparing forceful dilatation and oesophogomyotomy in patients with achalasia. Gut 1989; 30: 299–304.
16Spechler, SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51 (suppl 1): 24–29.
17Dent, J, Holloway, RH, Toouli, J, Dodds, WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gut 1988; 29: 1020–28.
18Ott, DJ, Gelfand, DW, Wu, WC. Sensitivity of single-contrast radiology in oesophageal disease: a study of 240 patients with endoscopically verified abnormality. Gastrointest Radiol 1983; 8: 105–10.
19Ott, DJ, Dodds, WJ, Wu, WC et al. Current status of radiology in evaluating for gastrooesophgeal disease. J Clin Gastroenterol 1982; 4: 365–75.
20De Caestecker, JS, Heading, RC. Oesophageal pH monitoring. Gastroenterol Clin North Am 1990; 19: 645–69.
21Stanciu, C, Hoare, RC, Bennet, JR. Correlation between manometric and pH tests for gastro-oesophageal reflux. Gut 1977; 18: 536–40.
22Hetzel, DJ. Controlled clinical trials of omeprazole in the long-term management of reflux disease. Digestion 1992; 51 (suppl 1): 35–42.
23Solcia, E, Fiocca, R, Havu, N, Dalvag, A, Carlsson, R. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion 1992; 51 (suppl 1): 82–92.
24Rosetti, M, Hell, K. Fundoplication for treatment of gastro-oesophageal reflux in hiatal hernia. World J Surg 1977; 1: 439–44.
25Dupin, B, Meric, B, Dumon, BF. Techniques, results and complications of oesophageal dilatation. Baillières Clin Gastroenterol 1987; 1: 809–20.
26Atkinson, M. Barrett's oesophagus – to screen or not to screen? Gut 1989; 30: 2–5.
27Hameerteman, W, Houthoff, HJ, Tytgat, GNJ. Early diagnosis of Barrett's carcinoma. Scand J Gastroenterol 1988; 23: 6–11.
28Quint, LE, Glazer, GM, Orringer, MB. Oesophageal imaging by MRI and CT: study of normal anatomy and neoplasm. Radiology 1985; 156: 727–31.
29Louizou, LA, Grigg, D, Atkinson, M et al. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology 1991; 100: 1303–10.
30McCaughan, JS, Nims, TA, Guys, JT et al. Photodynamic therapy for oesophageal tumours. Arch Surg 1989; 124: 74–80.
31Hagenmuller, F, Sander, C, Sander, R, Ries, G, Classen, M. Palliation of obstructive oesophageal and cardial carcinomas with laser and endoluminal iridium radiation. Baillières Clin Gastroenterol 1987; 1: 917–22.
32Wolfe, WG, Burton, GV, Seillger, HF et al. Early results with combined modality therapy for carcinoma of the oesophagus. Ann Surg 1987; 205: 563–71.
33Diehl, JT, Hermann, RE, Cooperman, AM, Hoerr, SO. Gastric carcinoma: a ten-year review. Ann Surg 1983; 198: 9–12.
34Steinheber, FU. Ageing and the stomach. Clin Gastroenterol 1985; 14: 657–88.
35Kurata, JH, Corboy, ED. Current peptic ulcer time trends. An epidemiological profile. J Clin Gastroenterol 1988; 10: 259–68.
36Tasman-Jones, C. Pathogenesis of peptic ulcer disease and gastritis: importance of aggressive and cytoprotective factors. Scand J Gastroenterol 1986; 21 (suppl 122): 1–5.
37Tasman-Jones, C, Maher, C, Thomsen, L, Lee, SP, Vanderwee, M. Mucosal defences and gastroduodenal disease. Digestion 1987; 37: 1–7.
38Corfield, A, Wagner, SA, Safe, AF, Mountford, RA, Clamp, JR. Sialic acid in human gastric aspiration. Clin Sci 1993; 84: 573–79.
39Marshall, BJ, Warren, RJ. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311–15.
40O'Connor, HJ, Dixon, MF, Wyatt, JI et al. Campylobacter pylori and peptic ulcer disease. Lancet 1987; ii: 633–34.
41Rokkas, T, Pursey, C, Uzoechina, E et al. Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 1987; 82: 1149–52.
42Forman, D, Newell, DG, Fullerton, F et al. Association between infection with Helicobacter pylori infection and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302–305.
43Veenendaal, RA, Pena, AS, Maijer, JL et al. Long-term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32: 1291–94.
44Sobala, GM, Crabtree, JE, Pentith, JA et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 94–96.
45Duggan, JM, Dobson, AJ, Johnson, H, Fahey, P. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut 1986; 27: 929–33.
46Jolobe, OM, Montgomery, RD. Changing clinical pattern of gastric ulcer: are anti-inflammatory drugs involved? Digestion 1984; 29: 164–70.
47Armstrong, CP, Blower, AL. Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut 1987; 28: 527–32.
48 Collier DSI, Pain, JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359–63.
49Jones, ST, Clague, RB, Eldridge, J, Jones, DM. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis. Br J Rheumatol 1991; 30: 16–20.
50Graham, DY, Lew, GM, Evans, DG et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991; 115: 266–69.
51Goodwin, CS, McNulty, CAM. Bacteriological and pharmacological basis for the treatment of Helicobacter pylori infection. In: Rathbone, BJ, Heatley, RV eds. Helicobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific Publications, 1992: 224–31.
52Suerbaun, S, Leying, H, Klemm, K, Opferkuch, W. Antibacterial activity of pantonazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; 10: 92–93.
53Labenz, J, Gyenes, E, Ruhl, GH, Borsch, G. Omeprazole plus amoxycillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491–95.
54Morgan, AG, Clamp, SE. OMGE international gastrointestinal bleeding survey, 1978–1986. Scand J Gastroenterol Suppl 1988; 144: 51–58.
55Wara, P, Berg, V, Amdrup, E. Factors influencing mortality in patients with bleeding peptic ulcer. Acta Clin Scand 1983; 149: 775–85.
56Holman, RAE, Davis, M, Gough, KR, Cartell, P, Britton, DC, Smith, RB. Value of centralised approach in management of haematemesis and melaena: experience in a district general hospital. Gut 1990; 31: 504–508.
57Llwellyn, JG, Pritchard, MH. Influence of age and disease state in nonsteroidal anti-inflammatory drug-associated gastric bleeding. J Rheumatol 1988; 15: 691–94.
58Allan, R, Dykes, PW. A study of factors influencing mortality rates from gastrointestinal haemorrhage. Q J Med 1976; 45: 533–50.
59Clason, AE, Macleod, DAD, Elton, RA. Clinical factors in the prediction of further haemorrhage or mortality in acute upper gastrointestinal haemorrhage. Br J Surg 1986; 73: 985–87.
60Swaine, CP, Story, DW, Brown, SG et al. Nature of the bleeding vessel in recurrently bleeding gastric ulcers. Gastroenterology 1986; 90: 595–608.
61Collins, R, Langman, MJS. Treatment with histamine H2 antagonists in acute upper gastrointestinal haemorrhage: implications of randomised trials. N Eng J Med 1985; 313: 660–66.
62Haglund, U. Role of histamine H2receptor antagonists in non-operative management of gastroduodenal ulcer haemorrhage. Scand J Gastroenterol Suppl 1987; 137: 39–42.
63Daneshmed, TK, Hawkey, CJ. Langman, MJS et al. Omeprazole v. placebo for acute upper gastrointestinal bleeding: a randomised double-blind controlled trial in 1154 patients. Gut 1990; 31: 1206 (Abstract).
64Barer, D, Ogilvie, AL, Henry, DA et al. Cimetidine and tranexamic acid in the treatment of acute upper gastrointestinal bleeding. N Eng J Med 1983; 308: 1571–75.
65Henry, DA, O'Connel, D. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ 1989; 289: 1142–46.
66Sacks, HS, Chalmers, TC, Blum, AL et al. Endoscopic haemostasis. An effective therapy for bleeding peptic ulcers. JAMA 1990; 264: 494–99.
67Steele, RJC. Endoscopic haemostasis for non-variceal upper gastrointestinal haemorrhage. Br J Surg 1989; 76: 219–25.
68Teenan, RP, Murray, WR. Late outcome of undersewing alone for gastric ulcer haemorrhage. Br J Surg 1990; 77: 811–12.
69Falk, GL, Hollinstead, JW, Gillett, DJ. Highly selective vagotomy in the treatment of complicated duodenal ulcer. Med J Aust 1990; 152: 574–76.
70Pinto-Correia, J, Martins, Alves M, Alexandrino, P, Silveira, J. Controlled trial of vasopressin and balloon tamponade in bleeding oesophageal varices. Hepatology 1984; 4: 885–88.
71Khan, D, Bornman, JC, Terblanche, J. A 10-year prospective evaluation of balloon tamponade and emergency injection sclerotherapy for actively bleeding oesophageal varices. Hepatopancreatobil Surg 1989; I: 207–11.
72Larson, AW, Cohen, H, Zweiban, B et al. Acute oesophageal varices sclerotherapy. Results of a prospective randomised controlled trial. JAMA 1986; 255: 497–500.
73Jensen, LS, Kararup, N. Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol 1989; 24: 339–45.
74Bullinore, DW, Miloszewski, KJA, Losowsky, MS. The prognosis of elderly subjects with oesophageal varices. Age Ageing 1989; 18: 35–38.
75Mc Evoy, A, Dutton, J, James, OFW. Bacterial contamination of small intestine is an important cause of occult malabsorption in the elderly. BMJ 1983; 287: 789–93.
76Montgomery, RD, Haboubi, NY, Mike, NH, Chesner, IM, Asquith, P. Causes of malabsorption in the elderly. Age Ageing 1986; 15: 235–40.
77Corazza, GR, Menozzi, MG, Strocchi, A et al. The diagnosis of small bowel bacterial overgrowth. Gastroenterology 1990; 98: 302–307.